There are several different types of glaucoma, which refers to a group of eye diseases that can cause permanent vision loss ...

Glaucoma can lead to vision loss with few warning signs. Regular eye exams can catch it early. Key indicators include early ...

A large number of studies have focused on mental health declines associated with glaucoma. For example, about one-third of ...

The study, conducted in 2022, highlights significant variations in glaucoma prevalence across different demographic groups, ...

When it comes to maintaining good eye health, some conditions require more than medication or corrective lenses.

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to ...

For her, comfort is key, and she does not mind searching through multiple shops to find the perfect frame. She believes that ...

A new study "Prevalence of Glaucoma Among US Adults in 2022" published in JAMA Ophthalmology, found that approximately 4.22 million people in the United States have glaucoma (1.62% of adults ages 18 ...

Glaucoma Therapeutics MarketThe global glaucoma therapeutics market is projected to be valued at approximately USD 6.9 ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced that ...

Ocular Therapeutix's Elutyx drug delivery platform offers sustained long-term effects. See why OCUL stock is a Buy.